Key result
Increasing prednisolone improves LVEF by ~21% in a patient with EGPA and inflammatory dilated cardiomyopathy.
Why the study?
Cardiac involvement is the main cause of death in EGPA, but detection of myocardial inflammation can be challenging with non-invasive imaging methods.
Case Report (n=1)
No
Endomyocardial biopsy may be required to detect active myocardial inflammation in EGPA patients with heart failure when non-invasive imaging modalities are negative.
Answers are grounded in this paper and cite their sources.
May support steroid escalation in EGPA cardiomyopathy; leaves open need for biopsy confirmation and prospective trials.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare type of systemic vasculitis. Cardiac involvement is the main cause of death in patients with this disease. We herein report a case of congestive heart failure in a patient with EGPA. Neither 67Ga scintigraphy nor cardiac magnetic resonance imaging detected inflammation of the myocardium; however, myocardial biopsy revealed numerous infiltrating inflammatory cells, thereby fulfilling the criteria of inflammatory dilated cardiomyopathy. We improved the left ventricular systolic function by increasing the patient's prednisolone dosage. This case shows that in some cases the detection myocardial inflammation - which allows for appropriate therapy - may only be achieved by myocardial biopsy.
No takes yet. Share an insight, caveat, or question.
Nakayama et al. (2018) conducted a case report in Dilated Cardiomyopathy with Eosinophilic Granulomatosis with Polyangiitis (n=1). Prednisolone was evaluated on Left ventricular ejection fraction. Increasing the prednisolone dose to /day in a patient with EGPA and inflammatory dilated cardiomyopathy improved left ventricular ejection fraction from 29% to 50%.
Synapse has enriched 10 related papers. Consider them for comparative context: